While the authors postulated that this response to pazopanib might be due to functional dependency on angiogenic pathways including upregulation of HIF and VEGF, we had additionally observed that genes involved in tumor progression and metastasis MMP13, ST6GAL2, and ENPP1 were downregulated by pazopanib. The gene discussed is ENPP1; the disease is neoplasm.